About
Shiloh Alsaad is a PhD researcher within the Bone and Joint Group at Southampton's Institute of Developmental Sciences, developing the UK's first human bone-derived self-healing biofunctionalised biomaterials as a dual targeting regenerative-anticancer system in the treatment of osteogenic sarcoma.
Under Dr Yanghee Kim, with support from Dr Janos Kanczler and Prof Jon Dawson, Shiloh is pioneering the development of human bone-derived extracellular matrix (ECM) hydrogels biofunctionalised with innovative medical nanoclays capable of replicating the native bone matrices and microenvironment, enabling further advancement within in vitro and ex vivo models for tissue regeneration and osteosarcoma research.
Previously at University College London's (UCL) Division of Surgery and Interventional Science, Shiloh specialised in nanotechnology and regenerative medicine, focusing on the development of the first highly structured 3D-olfactory ensheathing neurospheroids. Embedded within newly synthesised self-assembled biounctionalised hydrogels, they were targeted towards regenerative neurogenesis-associated applications.
Since joining the University of Southampton's Centre for Human Development, Stem Cells and Regeneration (CHDSCR), Shiloh has advanced his research through the support of Future Worlds Social Impact and Innovation Scholarship, coupled with Dr Yanghee Kim's prestigious Royal Society International Science Partnerships Fund (ISPF) Award, in collaboration with Professor Byoung Soo Kim at Pusan National University, South Korea.
Outside of Shiloh's research within the Institute of Developmental Sciences, he is passionate about bridging the applications of regenerative medicine and quantum mechanics by leveraging the superposition and tunnelling effects of subatomic particle adjustment in the advancement of next-gen human-machine integrative biocybernetic technologies and therapeutics.